Loading…
Coya Therapeutics, Inc. is projected to rise to $6.88 by 2027, a +31% move from its current price of $5.26. COYA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.08 | $5.26 | $5.45 | +0.08% |
| Jul 14 | $5.01 | $5.27 | $5.54 | +0.16% |
| Jul 15 | $4.96 | $5.27 | $5.61 | +0.24% |
| Jul 16 | $4.92 | $5.28 | $5.66 | +0.32% |
| Jul 17 | $4.88 | $5.28 | $5.72 | +0.40% |
| Jul 18 | $4.85 | $5.29 | $5.76 | +0.48% |
| Jul 19 | $4.82 | $5.29 | $5.81 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.82 | $5.29 | $5.81 | +0.56% |
| Week 2 | $4.66 | $5.32 | $6.07 | +1.12% |
| Week 3 | $4.55 | $5.35 | $6.29 | +1.68% |
| Week 4 | $4.46 | $5.38 | $6.49 | +2.24% |
| Week 5 | $4.38 | $5.41 | $6.67 | +2.81% |
| Week 6 | $4.32 | $5.44 | $6.84 | +3.38% |
| Week 7 | $4.27 | $5.47 | $7.01 | +3.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Coya Therapeutics, Inc. is a clinical-stage biotechnology company that develops proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate pipeline includes Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
COYA 302 is a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages. It is in a Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer's disease, and Parkinson's disease.
The company also maintains pre-clinical product candidates including COYA 301, COYA 303, COYA 201, COYA 206, and COYA 101, and it has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
COYA Therapeutics, Inc. trades under the symbol COYA. Its current price is $5.36 per share and its market capitalization is $125.73M, with a rank of 4093 in market capitalization.
The outlook reflects a year-by-year forecast path, with 2026 showing an average price of $5.36, and a multi-year trajectory toward higher levels. Notably, 2040 carries an average of $23.82 and 2050 an average of $43.15, with higher-end forecasts signaling substantial upside over time. These figures imply meaningful upside relative to the current level, though outcomes are not guaranteed.
A major floor 31.8% below — a decisive break under it would weaken the trend.
The nearest floor, 16.2% below — buyers have tended to step in here.
The nearest ceiling, 15.4% above — a clean break opens room to run.
A major ceiling 31.3% above — clearing it would confirm fresh momentum.
Key COYA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COYA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.48 | Sell | $5.42 | Sell |
| MA 10 | $5.63 | Sell | $5.46 | Sell |
| MA 20 | $5.33 | Sell | $5.33 | Sell |
| MA 50 | $4.86 | Buy | $5.02 | Buy |
| MA 100 | $4.68 | Buy | $4.92 | Buy |
| MA 200 | $5.17 | Buy | $5.12 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.57 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -13.23 | Neutral |
| Williams %R (14) | -86.17 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -2.41 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 13.83 | Buy |
| TRIX (15) | 0.72 | Buy |
| Awesome (5,34) | 0.41 | Buy |
| Ultimate (7,14,28) | 35.28 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 5.25 | Buy |
| ADX (14) | 16.22 | Neutral |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is described as BULLISH by the current sentiment, with RSI(14) at 50. The 50-day moving average stands at $4.83 and the 200-day moving average at $5.17.
Key levels to watch include support at $4.41 and resistance at $6.07. The 30-day price range runs from a low of $4.19 to a high of $6.86. The security exhibits an annualized volatility of 70%., indicating elevated price variability over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.78 | $5.26 | $7.19 | 0% | Neutral | |
| $5.32 | $6.88 | $9.49 | +31% | Bullish | |
| $5.23 | $7.01 | $10.12 | +33% | Bullish | |
| $5.72 | $7.91 | $11.84 | +50% | Bullish | |
| $5.52 | $7.86 | $12.13 | +49% | Bullish | |
| $5.41 | $7.90 | $12.51 | +50% | Bullish | |
| $6.90 | $10.32 | $16.71 | +96% | Bullish | |
| $7.86 | $12.03 | $19.89 | +129% | Bullish | |
| $8.50 | $13.28 | $22.40 | +152% | Bullish | |
| $9.32 | $14.87 | $25.53 | +183% | Bullish | |
| $12.52 | $22.00 | $40.66 | +318% | Bullish | |
| $19.08 | $39.87 | $81.91 | +658% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.78 | $5.26 | $6.32 | +0.00% |
| August 2026 | $4.56 | $5.42 | $6.66 | +3.10% |
| September 2026 | $4.71 | $5.65 | $7.04 | +4.26% |
| October 2026 | $4.59 | $5.56 | $7.01 | -1.67% |
| November 2026 | $4.45 | $5.42 | $6.90 | -2.50% |
| December 2026 | $4.56 | $5.60 | $7.19 | +3.23% |
Click any year to see its month-by-month COYA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, COYA could reach as high as $7.19, with a base case around $5.26 and support toward $3.78 — roughly 0% from $5.26. A consolidation phase looks the most probable path here.
Expect COYA to range from $5.32 to $9.49 through 2027. The $6.88 average target implies a +31% move from current prices. That is up +31% on the projected 2026 average. Momentum favours further upside here.
The COYA price prediction for 2028 points to an average of $7.01 (low $5.23, high $10.12) — a potential gain of +33% on today's $5.26. Buyers look set to stay in control over this stretch.
In 2029, COYA is projected to trade between $5.72 and $11.84, averaging $7.91 — a potential gain of +50% from today's $5.26. That is up +13% on the projected 2028 average. Momentum favours further upside here.
Coya Therapeutics, Inc.'s 2030 outlook centres on $7.86, within a $5.52 to $12.13 range. That is -1% versus the projected 2029 average. That marks a +49% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, COYA could reach as high as $12.51, with a base case around $7.90 and support toward $5.41 — roughly +50% from $5.26. Momentum favours further upside here.
Expect COYA to range from $6.90 to $16.71 through 2032. The $10.32 average target implies a +96% move from current prices. That is up +31% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The COYA price prediction for 2033 points to an average of $12.03 (low $7.86, high $19.89) — a potential gain of +129% on today's $5.26. Momentum favours further upside here.
In 2034, COYA is projected to trade between $8.50 and $22.40, averaging $13.28 — a potential gain of +152% from today's $5.26. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Coya Therapeutics, Inc.'s 2035 outlook centres on $14.87, within a $9.32 to $25.53 range. That is up +12% on the projected 2034 average. That marks a +183% change versus current levels. Momentum favours further upside here.
By 2040, COYA could reach as high as $40.66, with a base case around $22.00 and support toward $12.52 — roughly +318% from $5.26. Buyers look set to stay in control over this stretch.
Expect COYA to range from $19.08 to $81.91 through 2050. The $39.87 average target implies a +658% move from current prices. That is up +81% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in COYA today (≈ 190.114068 COYA) could be worth
$7,579.92
+$6,579.92 (+658%) by 2050 · US Dollar
Based on the average projected COYA price of $39.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in COYAwould be worth at today's price.
$1,000 invested in COYA on Jul 10, 2025 (≈ 158.102772 COYA) would be worth
$831.62
-$168.38 (-16.8%) today · 0.83× · US Dollar
Based on a COYA entry price of $6.32 vs. today's $5.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.86 | $897.61 | -10.2% |
| 1 month ago | $4.41 | $1,192.74 | +19.3% |
| 3 months ago | $4.17 | $1,261.39 | +26.1% |
| 6 months ago | $4.75 | $1,107.37 | +10.7% |
| 1 year ago | $6.32 | $831.62 | -16.8% |
| All time (3.5y) ago | $4.57 | $1,150.98 | +15.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COYA forecast.
Our base-case forecast reaches $11.00 around 2033.
Implied market cap at $11.00: $258.03M
The multi-year forecast begins in 2026 with a min price of $3.78, an avg of $5.36, and a max of $7.41, with ROI shown as 0 and sentiment Neutral.
From 2027 through 2031 the forecast turns bullish and shows rising averages: 2027 avg $7.07 (ROI 32), 2028 avg $7.21 (ROI 34), 2029 avg $8.20 (ROI 52.9), 2030 avg $8.11 (ROI 51.2), 2031 avg $8.17 (ROI 52.4).
In the 2032–2035 window the model projects further upside: 2032 avg $10.91 (ROI 103.5), 2033 avg $12.73 (ROI 137.6), 2034 avg $14.07 (ROI 162.5), 2035 avg $15.88 (ROI 196.3).
Longer-horizon forecasts show pronounced upside: 2040 avg $23.82 (ROI 344.5), max $44.98, and 2050 avg $43.15 (ROI 705), max $90.90, with sentiment remaining BULLISH. These figures illustrate a potential long-run ascent, tempered by the usual uncertainty around future outcomes.
Tap a question to reveal the answer.
2030 avg $8.11, min $5.62, max $12.68; ROI 51.2; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages (2027 avg $7.07; 2028 avg $7.21; 2029 avg $8.20; 2030 avg $8.11; 2031 avg $8.17) and ROIs ranging from 32 to 52.4 across years; 2026 is Neutral with avg $5.36 and ROI 0.
Yes. The 2050 forecast shows max $90.90, avg $43.15, ROI 705, sentiment BULLISH.
Current price $5.36; Market cap $125.73M.
30-day range $4.19 to $6.86; RSI(14) 50; SMA50 $4.83; SMA200 $5.17; support $4.41; resistance $6.07; annualized volatility 70%.
Coya Therapeutics, Inc. Community Discussion
0Share your Coya Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.